Dementia in Parkinson's disease: Common and treatable

Lancet Neurology

Volumn 3, Issue 8, 2004, Pages 456-

  McKeith, Ian ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; RIVASTIGMINE; TACRINE;

AGE DISTRIBUTION; AKINESIA; APATHY; BEHAVIOR DISORDER; BRAIN ATROPHY; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG TOLERABILITY; DYSPHONIA; EXTRAPYRAMIDAL SYMPTOM; HALLUCINATION; HIPPOCAMPUS; HUMAN; LEWY BODY; MEMORY DISORDER; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; ONSET AGE; PARIETAL LOBE; PARKINSON DISEASE; PRIORITY JOURNAL; SHORT SURVEY; SLEEP DISORDER;

EID: 3142640599     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(04)00821-X     Document Type: Letter

References (10)

1. Parkinson J. An essay on the shaking palsy. 1817;Sherwood, Neely and Jones, London
2. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease - an 8-year prospective study. Arch Neurol. 60:2003;387-392
3. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol. 2:2003;229-237
4. Zarranz JJ, Alegre J, Gomez-Esteban JC, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 55:2004;164-173
5. McKeith IG, Burn D. Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. DeKosky ST. Neurologic clinics. 2000;865-883 WB Sauders Company, Philadelphia
6. Gómez-Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT. Clinical and quantitative pathological correlates of dementia with Lewy bodies. Neurology. 53:1999;1284-1291
7. Reading PJ, Luce AK, McKeith IG. Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment. Mov Disord. 16:2001;1171-1174
8. Aarsland D. Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry. 72:2002;708-712
9. Aarsland D. Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry. 73:2002;354
10. McKeith I, Del-Ser T, Spano PF, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet. 356:2000;2031-2036